Thanks, Patrick, and good morning to everyone on today's call. We had good performance in fiscal Q3 with gross billings ahead of expectations and backlog increasing year-over-year. Total gross billing were $20.3 billion, up 9% year-over-year, which is above the high end of our guidance range. We were pleased to see growth across both Endpoint and Advanced Solutions in the quarter, which supports our thesis that the IT market has returned to growth. And we grew at a slight premium to the market. In Q3, there was 27.6% reduction from gross billings to net revenue, which was consistent with expectations and a slightly higher difference between the two measures year-over-year driven by the mix of software and as-a-service offerings, which are recorded on a net basis. From a technology perspective, Endpoint Solutions grew 5% driven by PCs, components, mobile and services. Advanced Solutions grew 12% driven by Hyve, Hybrid Cloud, Software and Services. Non-GAAP gross profit was $961 million or 4.7% of gross billings, down 1% year-over-year or 50 basis points primarily driven by tough year-over-year comparison in Hyve and business mix. As we commented in the prior quarter, Hyve, which sits within Advanced Solutions, experienced elevated margins in the prior year due to cost recoveries and incremental recognition of inventory carrying costs as we sold through aged inventory in 2023. Non-GAAP SG&A expense was $568 million or 2.8% of non-GAAP gross billings, which represented a 30 basis point improvement from the prior year. As Patrick discussed, we are introducing a new metric comparing non-GAAP SG&A expense to gross profit as we believe gross profit is a better metric to compare than reported revenue as more of our business is being netted down. The cost to gross profit percentage in Q3 was 59.1%, representing a slight improvement year-over-year driven by disciplined cost management while continuing to balance investments in strategic growth areas. Our cost to gross profit percentage will be an important metric and focus as we grow our business. Non-GAAP operating income was $393 million, down 1% year-over-year. Non-GAAP operating margin was 1.9% of gross billings, down 20 basis points year-over-year, which was consistent with expectations. The decline was primarily due to the Hyve headwinds, which we previously discussed and the mix within our distribution business. On a reported revenue basis, non-GAAP operating margin was 2.68%, down 16 basis points from the prior year and consistent with expectations. Interest expense and finance charges were $80 million, and the non-GAAP effective tax rate was approximately 21%. Our effective tax rate was lower than expected due to favorable discrete items and mix. Total non-GAAP net income was $245 million, and non-GAAP diluted EPS was $2.86, which was slightly above the midpoint of our guidance range. Now turning to the balance sheet. For Q3, net working capital was $3.5 billion, down $39 million from Q2. And the cash conversion cycle based on net revenue was 21 days. This represented an improvement of two days year-over-year and quarter-over-quarter. As a result of our strong working capital management, free cash flow was approximately $339 million for the quarter. We returned $91 million to stockholders in quarter three with $57 million of share repurchases and $34 million of dividend payments. Year-to-date, we have generated $530 million of free cash flow and returned $614 million to stockholders in the form of buybacks and dividends. Similarly, since fiscal '22, we have repurchased 1.25 billion shares and paid $315 million of dividends totaling $1.6 billion or 100% of our free cash flow. For quarter four, on a sequential basis, we expect to slightly increase our capital allocation towards share repurchases. For the current quarter, our Board of Directors has approved a dividend of $0.40 per common share, which will be payable on October 25, 2024, to stockholders of record as of the close of business on October 11, 2024. We ended the quarter with $854 million of cash and cash equivalents and debt of $4.1 billion. Our gross leverage ratio was 2.3x. And net leverage was 1.8x, which is within our target range. In Q3, we also paid off $700 million of senior notes that matured in August at 1.25%. Now moving to our outlook for the fiscal fourth quarter. For Q4, we expect non-GAAP gross billings to be in the range of $20.5 billion to $21.5 billion, representing growth of 6% at the midpoint. We expect our gross net percentage adjustment to be approximately 27.2%, which translates to $14.9 billion to $15.7 billion of reported revenue. Our guidance is based on a euro to dollar exchange rate of 1.1. Non-GAAP net income is expected to be in the range of $239 million to $282 million. And non-GAAP diluted EPS is expected to be a range of $2.80 per diluted share to $3.30 per diluted share, which is based on weighted average shares outstanding of approximately 84.5 million. Our non-GAAP tax rate is expected to be approximately 22%, and interest expense is expected to be $80 million. As we close out Q4, we expect to generate approximately $1 billion in free cash flow for the fiscal year and are committed to returning excess free cash flow to stockholders, keeping in mind investments needed to strategically grow our business. We expect IT spend demand will continue to expand in Q4 and into fiscal '25, which will result in increased working capital and also an increase in cash days, but is expected to result in accretive returns as these investments fell through in fiscal '25. In closing, we believe we remain well positioned to benefit from the IT market recovery and have a strong balance sheet to fund our unique capabilities, allowing us to be the global partner of choice in IT distribution. We are now ready to begin the Q&A portion of the call. Operator?